{"name":"Peter Rossing","slug":"peter-rossing","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9JaHFNNFNRZ1RZYnJfUC1nZVZiSy1iWF9yeF9oTkNwdUQ0Um9NQ1RtTm4tNWk2ZnI3UTZKV1lVdmJUX0NPYnhRbVJBRF83RUNwZmRPbU5KV3MxQWtwYk9vclBjQlVSWWpFZTFr?oc=5","date":"2024-09-03","type":"pipeline","source":"Wiley Online Library","summary":"Finerenone and left ventricular hypertrophy in chronic kidney disease and type 2 diabetes - Wiley Online Library","headline":"Finerenone and left ventricular hypertrophy in chronic kidney disease and type 2 diabetes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9kbU1rTFJCWkY0NE1wMDVVNFEzb1djZl8yQXNrbU9qdW5lV1lUcm5EUnBhbTNhSHpZcXZZVjBjYlFjT19icWlRdDVQS1lsMUFubXdTd0dxampUWk4xd1BF?oc=5","date":"2024-06-24","type":"regulatory","source":"Nature","summary":"Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial - Nature","headline":"Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPZ21QR0dKblVnUUhrdGdpWHh2WTdpU21DczNKalBQQ2ppS3ZpQjV1Tjk2YXEza01GS3N1Yl9hbnlxdTQ1Y3U0TE1tb050LTExMWpNbHFGTHAyTHdfNWdpd2RtWUJKWEFKOWFyb0lrbDlDYUltZ3BsZ2x6Zlo5QktCU2FBYzk5TWJvaS1nX2hjVWlJcHZzMndaUFRzVzF4ZUdiY0xlTjRFa2dXYTF6TEhRY0pFSGdyenk5?oc=5","date":"2024-06-24","type":"regulatory","source":"Pharmacy Times","summary":"Results From the FLOW Trial Show Benefits of Semaglutide on Chronic Kidney Disease - Pharmacy Times","headline":"Results From the FLOW Trial Show Benefits of Semaglutide on Chronic Kidney Disease","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-02-12","type":"pipeline","source":"Medical Dialogues","summary":"Bayer Kerendia granted expanded indication in EU for broad range of patients with chronic kidney disease, ... - Medical Dialogues","headline":"Bayer Kerendia granted expanded indication in EU for broad range of patients with chronic kidney disease, ...","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE5kRGNRMDVCWXFtcHBoeFNvdlVfZWRHSE83aFNlTG1KQ2dxamdCWkdXZ0FtYndUUDhZX0h2ZndBM29KR19aZUgtbFV0QlFfdHpTTEkzTVRVNzBIbGJDeG1ZTw?oc=5","date":"2020-10-23","type":"pipeline","source":"NEJM","summary":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes - NEJM","headline":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxPUDNPNzFqMTdmWTVPem0yUG1FcW14dTJraHoxNVBJQUcxanpqeWtISEhsZUJpVUN5VjMyUEYtZ1oyN2l1WU1sZGZLcDR0eWVXTzhkWTdQTkkwcmpmRG94eE1TQzIzNDkwTEtTR3VFTzlkYldreWI4R21aSzQ4WG9zZzFFOERpel83d0NYWUVhYTVwRGJMbUxFcmVEbDFBY3o2VS1uN1l1LXZnam83SUpvZGRscl85VGYxWWJSZy1kZGhHNjVXaDJoM3U0cVRORThqRGdta1Q2U0dpekFFSkw1MUZTcmIzdjRtV0l5NmRXSlVJcm1NeG5ZNmhxNEp1ZjdtdVN4aDljUWhHN0lxdFJsZQ?oc=5","date":"2020-10-14","type":"pipeline","source":"European Medical Journal","summary":"Kidney Disease: Improving Global Outcomes (KDIGO) New Guideline for Diabetes Management in Chronic Kidney Disease: A Meet-the-Expert Session - European Medical Journal","headline":"Kidney Disease: Improving Global Outcomes (KDIGO) New Guideline for Diabetes Management in Chronic Kidney Disease: A Mee","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}